Capabilities · Analytical & stability services

Impurities & extractables / leachables

A proposed analytical domain for identifying and quantifying unexpected chemical species, connecting product compositions with their manufacturing and packaging materials.

PlannedCatalogue scope

Illustrative unbranded autosampler vial detail.
Illustrative unbranded autosampler vial detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Impurity analysis and extractables profiling are presented as planned technical domains. The specific formulation, material interfaces and chosen detection techniques would define the exact evaluation scope.

The initial project plan focuses on designated formulation and filling modules. The proposed impurities and extractables catalogue entry represents an expansion and would require independent scope confirmation.

Forced degradation studies and packaging extractables represent separate analytical disciplines. Inclusion in a common listing does not establish that identical analytical strategies would suit both investigative branches.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Primary packaging componentsPrimary packagingAssessment of container materials would require consideration of appropriate extraction solvents and conditions.Catalogue scopePlanned
Process contact materialsEvaluation of manufacturing lines would need analytical strategies to trace compounds migrating into formulations.Catalogue scopePlanned
Degradation productsStability studiesAnalysis of the active substance would depend on methodologies to isolate and characterise derived variants.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Analytical strategy formulation

Definition of target compounds, relevant matrices and the appropriate separation or detection methodology.

02 · Process stage

Planned

Extraction model design

Selection of solvents, conditions and parameters designed to generate representative analytical samples.

03 · Process stage

Planned

Method parameter establishment

Identification of suitable chromatographic conditions required to achieve the necessary analytical sensitivity.

04 · Process stage

Planned

Execution of analytical techniques

Implementation of defined laboratory approaches to isolate, identify and quantify the chemical species.

05 · Process stage

Planned

Toxicological threshold assessment

Correlation of detected quantities against applicable safety limits and established qualification thresholds.

06 · Process stage

Planned

Technical report compilation

Assembly of chromatograms, spectral data and interpreted findings into a formal scientific summary.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Container-closure integrity testing

Presentation-specific integrity questions and the supporting method.

Explore proposed scope

02PlannedCatalogue scope

Raw-material & finished-product testing

Material identity, specifications and product-specific test scope.

Explore proposed scope

03PlannedCatalogue scope

Process & cleaning validation support

Defined scope, protocols, acceptance criteria and evidence packages.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Material composition data
Detailed information regarding the formulation, process components or container systems.
Laboratory infrastructure
Relevant installed instrumentation, appropriate qualification and an approved analytical scope.
Methodology evidence
Defined parameters, appropriate technique justification and the required detection capabilities.
Quality accountability
Controlled record generation, data integrity provisions, review steps and decision rights.
Regulatory framework
Applicable pharmacopoeial expectations and toxicological guidance for the intended product.
Technical agreement
Responsibilities, confidentiality boundaries and data disclosure rules for any analytical engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating impurities or extractables testing service.

Are extractables and leachables identical?

No. The proposed domain distinguishes between theoretical compounds extracted under extreme conditions and those migrating into a product during normal storage.

What information helps define the question?

Identify the intended product formulation, packaging materials, process components and the specific analytical target. Confidential information should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, methodological scope, necessary permissions, equipment evidence and a documented agreement would need to be established before any commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma